Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.469NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.19NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.19NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.311NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.311NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.311NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.93NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.93NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.93NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.104NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.104NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.104NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.258.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.258.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.225NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.225NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.225NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.2.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.2.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AV.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AV.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AV.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.309NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.309NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.309NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.105NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.105NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.105NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.1.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.258.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.258.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.307NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.307NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.307NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.171NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used